CD20-Negative Circulating Plasmablasts Are Target for New B Cell Therapies in Anti-CCP Positive RA | Immunopathology & Immunotherapy | Scoop.it
Anti-citrullinated protein antibodies in RA are produced by circulating plasmablasts, renewed from memory B cell pool.